 |
Lisofylline |
|---|---|
| Trade Name | |
| Orphan Indication | Patients undergoing induction therapy for acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1999-06-10 00:00:00 |
| Sponsor | Cell Therapeutics, Inc.;501 Elliott Avenue West, Suite 400;Seattle, Washington, 98119 |
